Anderman Todd
SEC insider (Form 3/4/5 filer). CIK 0002039533. Chief Legal Officer at OCULAR THERAPEUTIX, INC (OCUL). 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2026. Located in BEDFORD, MA.
Companies Anderman Todd has filed insider reports for
- OCULAR THERAPEUTIX, INC (OCUL): Officer, Chief Legal Officer
Anderman Todd
CIK: 0002039533
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OCUL
OCULAR THERAPEUTIX, INC
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 8, 2026OCUL
OCULAR THERAPEUTIX, INC
SaleDirect12K shares at avg. $7.29$87K - Jan 2, 2026OCUL
OCULAR THERAPEUTIX, INC
AwardDirect64.9K shares- - Oct 8, 2025OCUL
OCULAR THERAPEUTIX, INC
SaleDirect11.1K shares at avg. $12.34$137K - Oct 7, 2024OCUL
OCULAR THERAPEUTIX, INC
AwardDirect98.7K shares-
1-4 of 4 transactions